Into pharma ' s roaring twenties

“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back down to ground level just in time to see the man draw back his fist in anger, and then.And then.With a piercing shriek, he lunged straight at my jaw –”Do you ever wake from a dream, marvelling at the inventiveness and detail of your subconscious mind? That disorienting moment where you lie blinking in darkness, for a second believing it really did happen. Suddenly you admire your own creative abilities in conjure up such a rich and immersive world.It felt so real.It ’s time to summon that subconscious creativity more readily. In the 2020s, such storytelling skills will be vital in finding and communicating a purpose. This skill will separate the winners from the losers. The 2010s: scaling incredible scienceThis past week, I asked twenty pharma and patient friends what they felt was, personally, their biggest moment of the 2010s – and their likely biggest of the next decade.For the decade just passed, the undoubted top choice was the ability to personalise medicine, with nearly two-thirds of respondents citing gene editing as the most impactful development.Simon Davies (Exec Director, Teen Cancer America) shared the moving story of Emily, the first young leuka...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news